Sino-Agri Leading Biosciences Co.,Ltd

SHSE:603970 Stock Report

Market Cap: CN¥4.1b

Sino-Agri Leading BiosciencesLtd Past Earnings Performance

Past criteria checks 2/6

Sino-Agri Leading BiosciencesLtd has been growing earnings at an average annual rate of 15.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.6% per year. Sino-Agri Leading BiosciencesLtd's return on equity is 14.1%, and it has net margins of 2.1%.

Key information

15.1%

Earnings growth rate

15.1%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate17.6%
Return on equity14.1%
Net Margin2.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02
Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit

Recent updates

Sino-Agri Leading BiosciencesLtd (SHSE:603970) Seems To Use Debt Quite Sensibly

Sep 27
Sino-Agri Leading BiosciencesLtd (SHSE:603970) Seems To Use Debt Quite Sensibly

Benign Growth For Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Underpins Stock's 25% Plummet

Jul 15
Benign Growth For Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Underpins Stock's 25% Plummet

Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02
Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit

Revenue & Expenses Breakdown

How Sino-Agri Leading BiosciencesLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603970 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2410,61021834471
30 Jun 2410,70623133966
31 Mar 2410,51422833772
31 Dec 2310,46022534865
30 Sep 2310,38022330568
30 Jun 2311,89022430360
31 Mar 2312,00721929748
31 Dec 2211,69921029746
30 Sep 2211,03220227939
30 Jun 2210,03919827638
31 Mar 229,03618025437
31 Dec 218,82217024738
30 Sep 218,93316224740
30 Jun 217,97815223837
31 Mar 217,10213824836
31 Dec 206,64113223934
30 Sep 206,11913024131
30 Jun 205,26012523431
31 Mar 204,52112022033
31 Dec 194,34211922631
30 Sep 194,19512123711
30 Jun 194,01512123613
31 Mar 193,85012023612
31 Dec 183,73511523712
30 Sep 183,56110924815
30 Jun 183,57310625111
31 Mar 183,629962715
31 Dec 173,503902684
30 Sep 173,489882670
31 Dec 163,398822710
31 Dec 153,234882580
31 Dec 142,875812380
31 Dec 132,488692110

Quality Earnings: 603970 has high quality earnings.

Growing Profit Margin: 603970's current net profit margins (2.1%) are lower than last year (2.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603970's earnings have grown by 15.1% per year over the past 5 years.

Accelerating Growth: 603970's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603970 had negative earnings growth (-2.3%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).


Return on Equity

High ROE: 603970's Return on Equity (14.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies